Alzheimer's disease & dementia

LSL60101 compound reduces neuroinflammation and improves cognition

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease. This is stated in the recent studies by the Research Group ...

Oncology & Cancer

Novel class of drugs may help treat deadly lymphoma

A new class of drugs that inhibits a 'master switch' involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.

Diseases, Conditions, Syndromes

Computer-aided drug design added to global fight against COVID-19

Life sciences company UCB is the first pharma company to join the COVID Moonshot crowdsourcing initiative, which involves the Diamond Light Source synchrotron facility in Oxfordshire and the Weizmann Institute of Science ...

page 1 from 6